3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Conditions
Brain Neoplasms
1702
Glioblastoma
1308
Glioma
995
Neuroblastoma
408
Central Nervous System Neoplasms
384
Astrocytoma
384
Gliosarcoma
286
Oligodendroglioma
238
Neoplasms
226
Breast Neoplasms
216
Meningioma
179
Medulloblastoma
172
Carcinoma, Non-Small-Cell Lung
149
Recurrence
147
Neoplasm Metastasis
138
Lung Neoplasms
138
Ependymoma
128
Melanoma
119
Sarcoma
117
Neurofibromatosis 1
110
Meningeal Carcinomatosis
107
Lymphoma
95
Neuroma, Acoustic
82
Diffuse Intrinsic Pontine Glioma
81
Precursor Cell Lymphoblastic Leukemia-Lymphoma
79
Head and Neck Neoplasms
79
Ovarian Neoplasms
73
Lymphoma, Follicular
73
Pheochromocytoma
71
Paraganglioma
68
Interventions
Sirolimus
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Vestibulocochlear Nerve Diseases
×
CNS
×
Clear all
NCT04241679
2024-04-25
ANTS
Washington University School of Medicine
Phase NA
Completed
10 enrolled
NCT01490476
2017-05-23
AFINF2
Assistance Publique - Hôpitaux de Paris
Phase 2
Completed
10 enrolled